The Food and Drug Administration, which had initially rejected the application, finally gave the company the green light
Neuralink, Elon Musk’s brain-implant company, said on Thursday it had received a green light from the US Food and Drug Administration (FDA) to kickstart its first in-human clinical study, a critical milestone after earlier struggles to gain approval.
Musk has predicted on at least four occasions since 2019 that his medical device company would begin human trials for a brain implant to treat severe conditions such as paralysis and blindness.
About Author
More Stories
Can you solve it? All you need to know about 2025
Drinking tea and coffee linked to lower risk of head and neck cancer in study
Esports are booming in Africa – but can its infrastructure keep pace?